Search results for " titers"
								 					Article
				
				Considerations for Improving Outcome in Biopharmaceutical Process Development
								For example, things like streamlining operations, optimizing titers and yields, evaluating cell lines and cell culture media, and controlling raw material variability can play a pivotal role in obtain…								
								 					Article
				
				Towards a Better Process Outcome
								Considerations for improving outcome in biopharmaceutical process development. 
	  
	
		Learn more > 
		
	
								
								 					Article
				
				Flavivirus Vaccine: Accelerate Development and Production with Modern Tools and Solutions
								The complex nature of flaviviruses makes process development technically challenging. In addition, vaccine production can be both costly and difficult to scale to meet market demands. This article giv…								
								 					Article
				
				Flexible Facilities for Viral Vector Manufacturing
								For example, for Duchene muscular dystrophy, the need (at current viral titers and downstream process recoveries) is about 200 L of production bioreactor culture per patient.” The batch size influence…								
								 					Article
				
				New Therapies Present Scaling Challenges
								Unlike mAb production—where the goal is to produce higher titers of cells containing the antibody—in cell-therapy, the cell itself is the therapeutic agent. The cells must, therefore, keep their integ…								
								 					Article
				
				Cell-Culture Advances Test Bioreactor Performance Models
								 
	The evolution of cell-culture technology is driving the need for improvements in modeling solutions. 
	By Cynthia A. Challener  
	Modeling and simulation are recognized to provide assistance i…								
								 					Article
				
				Scale-Up Model of a mAb Process from Microbioreactor to XDR-1000
								
	READ ARTICLE >>
	In process development, it is desirable to test process parameters in small scale and later scale up the process into larger production scale. A theoretical scale-up study was per…								
								 					Article
				
				Getting a Handle on Biopharma’s Most Critical Quality Attributes and Quality Control
								
	While the multiple attributes method gains ground and traditional lab methods improve, broad efforts are underway to determine biopharmaceuticals’ most significant critical quality attributes and en…								
								 					Article
				
				What’s New in Upstream Technologies
								The low-footprint integrated system delivers high cell densities and viral titers as well as homogeneous cell distribution throughout the fixed-bed. 
	According to the company, the bioreactor offers…								
								 					Article
				
				A Look at the Affinity Chromatography Landscape
								Resin suppliers have in recent years been challenged to increase the productivity of the capture chromatography process to enable more efficient purification of increasingly high titers. They have als…